These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


240 related items for PubMed ID: 9705381

  • 1. Comparison of NucliSens and Amplicor monitor assays for quantification of human immunodeficiency virus type 1 (HIV-1) RNA in plasma of persons with HIV-1 subtype A infection in Abidjan, Côte d'Ivoire.
    Nkengasong JN, Kalou M, Maurice C, Bile C, Borget MY, Koblavi S, Boateng E, Sassan-Morokro M, Anatole-Ehounou E, Ghys P, Greenberg AE, Wiktor SZ.
    J Clin Microbiol; 1998 Sep; 36(9):2495-8. PubMed ID: 9705381
    [Abstract] [Full Text] [Related]

  • 2. Quantification of RNA in HIV type 1 subtypes D and G by NucliSens and Amplicor assays in Abidjan, Ivory Coast.
    Nkengasong JN, Bile C, Kalou M, Maurice C, Boateng E, Sassan-Morokro M, Rayfield M, Coulibaly D, Greenberg AE, Wiktor SZ.
    AIDS Res Hum Retroviruses; 1999 Apr 10; 15(6):495-8. PubMed ID: 10221526
    [Abstract] [Full Text] [Related]

  • 3. Multicenter comparison of Roche COBAS AMPLICOR MONITOR version 1.5, Organon Teknika NucliSens QT with Extractor, and Bayer Quantiplex version 3.0 for quantification of human immunodeficiency virus type 1 RNA in plasma.
    Murphy DG, Côté L, Fauvel M, René P, Vincelette J.
    J Clin Microbiol; 2000 Nov 10; 38(11):4034-41. PubMed ID: 11060065
    [Abstract] [Full Text] [Related]

  • 4. Field evaluation of an improved assay using a heat-dissociated p24 antigen for adults mainly infected with HIV-1 CRF02_AG strains in Côte d'Ivoire, West Africa.
    Bonard D, Rouet F, Toni TA, Minga A, Huet C, Ekouévi DK, Dabis F, Salamon R, Rouzioux C, ANRS 1220 PRIMO-CI Study Group.
    J Acquir Immune Defic Syndr; 2003 Nov 01; 34(3):267-73. PubMed ID: 14600570
    [Abstract] [Full Text] [Related]

  • 5. Dual infection with human immunodeficiency virus type 1 and type 2: impact on HIV type 1 viral load and immune activation markers in HIV-seropositive female sex workers in Abidjan, Ivory Coast.
    Nkengasong JN, Kestens L, Ghys PD, Koblavi-Dème S, Otten RA, Bilé C, Maurice C, Kalou M, Laga M, Wiktor SZ, Greenberg AE.
    AIDS Res Hum Retroviruses; 2000 Sep 20; 16(14):1371-8. PubMed ID: 11018856
    [Abstract] [Full Text] [Related]

  • 6. Distribution of HIV-1 subtypes among HIV-seropositive patients in the interior of Côte d'Ivoire.
    Nkengasong JN, Luo CC, Abouya L, Pieniazek D, Maurice C, Sassan-Morokro M, Ellenberger D, Hu DJ, Pau CP, Dobbs T, Respess R, Coulibaly D, Coulibaly IM, Wiktor SZ, Greenberg AE, Rayfield M.
    J Acquir Immune Defic Syndr; 2000 Apr 15; 23(5):430-6. PubMed ID: 10866237
    [Abstract] [Full Text] [Related]

  • 7. Comparison of three different commercial methods for measuring plasma viraemia in patients infected with non-B HIV-1 subtypes.
    Holguín A, de Mendoza C, Soriano V.
    Eur J Clin Microbiol Infect Dis; 1999 Apr 15; 18(4):256-9. PubMed ID: 10385013
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of three different commercial procedures for quantifying human immunodeficiency virus type-1 RNA levels.
    Aschbacher R, Monari P, Lolli S, Donzelli C, Colangeli V, Vignoli M, Ramazzotti E, Furlini G, Re MC.
    New Microbiol; 1999 Jan 15; 22(1):1-9. PubMed ID: 10190111
    [Abstract] [Full Text] [Related]

  • 9. Lack of effect of chemokine receptor CCR2b gene polymorphism (64I) on HIV-1 plasma RNA viral load and immune activation among HIV-1 seropositive female workers in Abidjan, Côte d'Ivoire.
    Adjé CA, Bilé CE, Kestens L, Koblavi-Deme S, Ghys PD, Maurice C, Kalou-Badirou M, Kabran N, Ekpini RE, Roels TH, Wiktor SZ, Nkengasong JN.
    J Med Virol; 2001 Aug 15; 64(4):398-401. PubMed ID: 11468722
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of the NucliSens EasyQ assay in HIV-1-infected individuals in South Africa.
    Stevens W, Wiggill T, Horsfield P, Coetzee L, Scott LE.
    J Virol Methods; 2005 Mar 15; 124(1-2):105-10. PubMed ID: 15664057
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of dried blood spot diagnosis using HIV1-DNA and HIV1-RNA Biocentric assays in infants in Abidjan, Côte d'Ivoire. The Pedi-Test DBS ANRS 12183 Study.
    Yapo V, d'Aquin Toni Td, Desmonde S, Amani-Bosse C, Oga M, Lenaud S, Menan H, Timité-Konan M, Leroy V, Rouzioux C.
    J Virol Methods; 2013 Nov 15; 193(2):439-45. PubMed ID: 23872283
    [Abstract] [Full Text] [Related]

  • 12. Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma.
    Cao Y, Ho DD, Todd J, Kokka R, Urdea M, Lifson JD, Piatak M, Chen S, Hahn BH, Saag MS.
    AIDS Res Hum Retroviruses; 1995 Mar 15; 11(3):353-61. PubMed ID: 7786581
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of a second-generation nucleic acid sequence-based amplification assay for quantification of HIV type 1 RNA and the use of ultrasensitive protocol adaptations.
    Notermans DW, de Wolf F, Oudshoorn P, Cuijpers HT, Pirillo M, Tiller FW, McClernon DR, Prins JM, Lange JM, Danner SA, Goudsmit J, Jurriaans S.
    AIDS Res Hum Retroviruses; 2000 Oct 10; 16(15):1507-17. PubMed ID: 11054264
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of NucliSens EasyQ HIV-1 assay for quantification of HIV-1 subtypes prevalent in South-east Asia.
    Lam HY, Chen JH, Wong KH, Chan K, Li P, Lee MP, Tsang DN, Yuen KY, Yam WC.
    J Clin Virol; 2007 Jan 10; 38(1):39-43. PubMed ID: 17110162
    [Abstract] [Full Text] [Related]

  • 15. Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a West African resource-limited setting.
    Rouet F, Ekouevi DK, Chaix ML, Burgard M, Inwoley A, Tony TD, Danel C, Anglaret X, Leroy V, Msellati P, Dabis F, Rouzioux C.
    J Clin Microbiol; 2005 Jun 10; 43(6):2709-17. PubMed ID: 15956387
    [Abstract] [Full Text] [Related]

  • 16. Measurement of HIV RNA in patients infected by subtype C by assays optimized for subtype B results in an underestimation of the viral load.
    Gottesman BS, Grosman Z, Lorber M, Levi I, Shitrit P, Mileguir F, Gottesman G, Chowers MY.
    J Med Virol; 2004 Jun 10; 73(2):167-71. PubMed ID: 15122788
    [Abstract] [Full Text] [Related]

  • 17. Quantitative and cost comparison of ultrasensitive human immunodeficiency virus type 1 RNA viral load assays: Bayer bDNA quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor monitor version 1.5.
    Elbeik T, Charlebois E, Nassos P, Kahn J, Hecht FM, Yajko D, Ng V, Hadley K.
    J Clin Microbiol; 2000 Mar 10; 38(3):1113-20. PubMed ID: 10699005
    [Abstract] [Full Text] [Related]

  • 18. Impact of HIV type 1 subtype variation on viral RNA quantitation.
    Parekh B, Phillips S, Granade TC, Baggs J, Hu DJ, Respess R.
    AIDS Res Hum Retroviruses; 1999 Jan 20; 15(2):133-42. PubMed ID: 10029245
    [Abstract] [Full Text] [Related]

  • 19. Field evaluation of the gag-based heteroduplex mobility assay for genetic subtyping of circulating recombinant forms of human immunodeficiency virus type 1 in Abidjan, Côte d'Ivoire.
    Sawadogo S, Adjé-Touré C, Bilé CE, Ekpini RE, Chorba T, Nkengasong JN.
    J Clin Microbiol; 2003 Jul 20; 41(7):3056-9. PubMed ID: 12843043
    [Abstract] [Full Text] [Related]

  • 20. Pediatric viral human immunodeficiency virus type 1 RNA levels, timing of infection, and disease progression in African HIV-1-infected children.
    Rouet F, Sakarovitch C, Msellati P, Elenga N, Montcho C, Viho I, Blanche S, Rouzioux C, Dabis F, Leroy V, Abidjan ANRS 049 Ditrame Study Group.
    Pediatrics; 2003 Oct 20; 112(4):e289. PubMed ID: 14523214
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.